jueves, 17 de abril de 2025

Daily pill from Eli Lilly helps patients control blood sugar, lose weight, Phase 3 study shows The results could give Lilly an edge in the increasingly competitive obesity market

https://www.statnews.com/2025/04/17/eli-lilly-orforglipron-diabetes-achieve-obesity/

No hay comentarios: